Childhood Vaccinations and Type 1 Diabetes

Type 1 diabetes (T1D) is the most common paediatric endocrine disease, and its frequency has been found to increase worldwide. Similar to all conditions associated with poorly regulated glucose metabolism, T1D carries an increased risk of infection. Consequently, careful compliance by T1D children w...

Full description

Bibliographic Details
Main Authors: Susanna Esposito, Elena Mariotti Zani, Lisa Torelli, Sara Scavone, Maddalena Petraroli, Viviana Patianna, Barbara Predieri, Lorenzo Iughetti, Nicola Principi
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-08-01
Series:Frontiers in Immunology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.667889/full
id doaj-36ee9748b5ca40048074844ff4cc920b
record_format Article
spelling doaj-36ee9748b5ca40048074844ff4cc920b2021-08-27T21:16:08ZengFrontiers Media S.A.Frontiers in Immunology1664-32242021-08-011210.3389/fimmu.2021.667889667889Childhood Vaccinations and Type 1 DiabetesSusanna Esposito0Elena Mariotti Zani1Lisa Torelli2Sara Scavone3Maddalena Petraroli4Viviana Patianna5Barbara Predieri6Lorenzo Iughetti7Nicola Principi8Paediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyPediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, ItalyPediatric Unit, Department of Medical and Surgical Sciences of the Mothers, Children and Adults, University of Modena and Reggio Emilia, Modena, ItalyPaediatric Clinic, Department of Medicine and Surgery, University Hospital, University of Parma, Parma, ItalyType 1 diabetes (T1D) is the most common paediatric endocrine disease, and its frequency has been found to increase worldwide. Similar to all conditions associated with poorly regulated glucose metabolism, T1D carries an increased risk of infection. Consequently, careful compliance by T1D children with schedules officially approved for child immunization is strongly recommended. However, because patients with T1D show persistent and profound limitations in immune function, vaccines may evoke a less efficient immune response, with corresponding lower protection. Moreover, T1D is an autoimmune condition that develops in genetically susceptible individuals and some data regarding T1D triggering factors appear to indicate that infections, mainly those due to viruses, play a major role. Accordingly, the use of viral live attenuated vaccines is being debated. In this narrative review, we discussed the most effective and safe use of vaccines in patients at risk of or with overt T1D. Literature analysis showed that several problems related to the use of vaccines in children with T1D have not been completely resolved. There are few studies regarding the immunogenicity and efficacy of vaccines in T1D children, and the need for different immunization schedules has not been precisely established. Fortunately, the previous presumed relationship between vaccine administration and T1D appears to have been debunked, though some doubts regarding rotavirus vaccines remain. Further studies are needed to completely resolve the problems related to vaccine administration in T1D patients. In the meantime, the use of vaccines remains extensively recommended in children with this disease.https://www.frontiersin.org/articles/10.3389/fimmu.2021.667889/fullautoimmunityinfectiontype 1 diabetesvaccinationvaccine
collection DOAJ
language English
format Article
sources DOAJ
author Susanna Esposito
Elena Mariotti Zani
Lisa Torelli
Sara Scavone
Maddalena Petraroli
Viviana Patianna
Barbara Predieri
Lorenzo Iughetti
Nicola Principi
spellingShingle Susanna Esposito
Elena Mariotti Zani
Lisa Torelli
Sara Scavone
Maddalena Petraroli
Viviana Patianna
Barbara Predieri
Lorenzo Iughetti
Nicola Principi
Childhood Vaccinations and Type 1 Diabetes
Frontiers in Immunology
autoimmunity
infection
type 1 diabetes
vaccination
vaccine
author_facet Susanna Esposito
Elena Mariotti Zani
Lisa Torelli
Sara Scavone
Maddalena Petraroli
Viviana Patianna
Barbara Predieri
Lorenzo Iughetti
Nicola Principi
author_sort Susanna Esposito
title Childhood Vaccinations and Type 1 Diabetes
title_short Childhood Vaccinations and Type 1 Diabetes
title_full Childhood Vaccinations and Type 1 Diabetes
title_fullStr Childhood Vaccinations and Type 1 Diabetes
title_full_unstemmed Childhood Vaccinations and Type 1 Diabetes
title_sort childhood vaccinations and type 1 diabetes
publisher Frontiers Media S.A.
series Frontiers in Immunology
issn 1664-3224
publishDate 2021-08-01
description Type 1 diabetes (T1D) is the most common paediatric endocrine disease, and its frequency has been found to increase worldwide. Similar to all conditions associated with poorly regulated glucose metabolism, T1D carries an increased risk of infection. Consequently, careful compliance by T1D children with schedules officially approved for child immunization is strongly recommended. However, because patients with T1D show persistent and profound limitations in immune function, vaccines may evoke a less efficient immune response, with corresponding lower protection. Moreover, T1D is an autoimmune condition that develops in genetically susceptible individuals and some data regarding T1D triggering factors appear to indicate that infections, mainly those due to viruses, play a major role. Accordingly, the use of viral live attenuated vaccines is being debated. In this narrative review, we discussed the most effective and safe use of vaccines in patients at risk of or with overt T1D. Literature analysis showed that several problems related to the use of vaccines in children with T1D have not been completely resolved. There are few studies regarding the immunogenicity and efficacy of vaccines in T1D children, and the need for different immunization schedules has not been precisely established. Fortunately, the previous presumed relationship between vaccine administration and T1D appears to have been debunked, though some doubts regarding rotavirus vaccines remain. Further studies are needed to completely resolve the problems related to vaccine administration in T1D patients. In the meantime, the use of vaccines remains extensively recommended in children with this disease.
topic autoimmunity
infection
type 1 diabetes
vaccination
vaccine
url https://www.frontiersin.org/articles/10.3389/fimmu.2021.667889/full
work_keys_str_mv AT susannaesposito childhoodvaccinationsandtype1diabetes
AT elenamariottizani childhoodvaccinationsandtype1diabetes
AT lisatorelli childhoodvaccinationsandtype1diabetes
AT sarascavone childhoodvaccinationsandtype1diabetes
AT maddalenapetraroli childhoodvaccinationsandtype1diabetes
AT vivianapatianna childhoodvaccinationsandtype1diabetes
AT barbarapredieri childhoodvaccinationsandtype1diabetes
AT lorenzoiughetti childhoodvaccinationsandtype1diabetes
AT nicolaprincipi childhoodvaccinationsandtype1diabetes
_version_ 1721187959143661568